Anzeige
Mehr »
Freitag, 04.07.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
122 Leser
Artikel bewerten:
(0)

Avalon GloboCare Corp.: Avalon GloboCare to Host The 3rd Annual International Scientific Forum on Exosome Research and Application (ISFERA) in Beijing on July 19, 2019

  • Co-organized with the Regenerative Medicine Foundation
  • Concurrent with the 7th Annual Lu Daopei Hematology Forum

FREEHOLD, NJ / ACCESSWIRE / April 17, 2019 / Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of innovative and transformative cell-based technologies and therapeutics, announced today that it will co-organize the 3rd Annual International Scientific Forum on Exosome Research and Application (ISFERA) with the Regenerative Medicine Foundation. The event will take place at the Beijing International Convention Center on July 19, 2019, concurrent with the 7th Annual Lu Daopei Hematology Forum. A panel of leading international experts will present scientific and clinical work related to exosomes and extracellular vesicles with respect to:

  • Standardization of clinical-grade stem cell exosome bio-production
  • Application of exosomal biomarkers in liquid biopsy
  • Correlation of exosomal biomarkers with cancer therapeutic resistance
  • Utilization of engineered exosomes as a novel therapeutic delivery system
  • "Exosomics" as a bioinformatic source in health and disease management

"We are excited and honored to co-organize this year's ISFERA with the Regenerative Medicine Foundation," stated David Jin, M.D., Ph.D., CEO and President of Avalon GloboCare Corp, as well as Chairperson of ISFERA 2019. "We look forward to building upon the previous success of this international meeting to help expand the scientific/clinical knowledge and application of exosome-based diagnostics and therapeutics," added Dr. Jin.

About Regenerative Medicine Foundation

Now entering its 16th year, the nonprofit Regenerative Medicine Foundation (RMF) fosters strategic collaborations to accelerate the development of regenerative medicine to improve health and deliver cures. RMF pursues its mission by producing its flagship World Stem Cell Summit; honoring leaders through the Stem Cell and Regenerative Medicine Action Awards; publishing The World Stem Report with its journal partner, Stem Cells Translational Medicine; and promoting policy and educational initiatives. The World Stem Cell Summit was founded by Bernard Siegel, J.D. and is produced by RMF. This annual event has earned its reputation as the world's most inclusive and expansive, interdisciplinary, networking, and partnering meeting in the stem cell science and regenerative medicine field. Global in scope, the Summit fosters biomedical research and translation, funding, and investments targeting cures. It is the single conference serving the diverse ecosystem of regenerative medicine stakeholders.

About Avalon GloboCare Corp.

Avalon GloboCare Corp. (NASDAQ: AVCO) is a leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative exosome technologies and cellular therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth, development, as well as competitiveness in both the domestic and global healthcare markets. Through its subsidiaries, namely GenExosome Technologies Inc. and Avactis Biosciences Inc., Avalon is establishing a leading role in the fields of exosome-based diagnostics ("liquid biopsy"), cellular immunotherapy (including CAR-T/CAR-NK), and regenerative medicine.

SOURCE: Avalon GloboCare Corp.



View source version on accesswire.com:
https://www.accesswire.com/542119/Avalon-GloboCare-to-Host-The-3rd-Annual-International-Scientific-Forum-on-Exosome-Research-and-Application-ISFERA-in-Beijing-on-July-19-2019

© 2019 ACCESS Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.